Form 8-K · Current Report · Filed 2026-03-24
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
Thermo Fisher Scientific Inc. has completed its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, with potential additional payments based on performance. The acquisition is expected to contribute $0.45 of adjusted earnings per share in the first year and approximately $175M of adjusted operating income by year 5, reflecting a double-digit internal rate of return. The deal strengthens Thermo Fisher's position in the clinical research market and is expected to drive greater productivity and faster decision-making for customers.
- Filer
- Thermo Fisher Scientific Inc. TMO · NYSE
- Filed
- Accession
- 0000097745-26-000066
- CIK
- 0000097745
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$478.12
Next session
+2.6%
Since filing
+20.1%
Latest close
$574.30
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from TMO reporting the same item, with the next session's move:
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Never miss another TMO filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.